Evidence map›Paper›PMID 42297443›Full record

ArticleJournal of microbiology and biotechnology2026

Enhancing the Antibacterial Activity of Endolysin against

Kexuan Gao, Yuhui Li, Yuxuan Wang, Chuanyan Zheng, Keyu Zhu, Xinru Mao, Jinlong Bai, Ruirui Hu, Bingbing Lei, Shengwei Hu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Phage therapy againstFrontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kexuan GaoCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Yuhui LiCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Yuxuan WangCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Chuanyan ZhengCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Keyu ZhuCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Xinru MaoCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Jinlong BaiCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Ruirui HuCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Bingbing LeiCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Shengwei HuCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Xia LiCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.
Wei NiCollege of Life Sciences, Shihezi University, Shihezi City, Xinjiang 832003, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of clinically isolated

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesEndopeptidasesKlebsiella pneumoniaeRecombinant Fusion ProteinsAnimalsKlebsiella InfectionsMiceMicrobial Sensitivity TestsPeptidoglycanWound InfectionAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesendolysinEndopeptidasesPeptidoglycanRecombinant Fusion ProteinsAntimicrobial activityAntimicrobial peptideEndolysinKlebsiella pneumoniaeSkin infection

Identifiers

PMID42297443
PMCPMC13268922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.